In vivo effects of curcumin and deferoxamine in experimental endometriosis

Background. Endometriosis is one of the most common chronic gynecological diseases. Objectives. The aim of the study was to examine the effects of curcumin and/or deferoxamine on cell proliferation in a rat model of endometriosis.

and Methods. Thirty female 12-week-old albino Wistar rats, weighing 200–250 g, were used in this study. All the rats underwent ovariectomy and 0.1-mg β-estradiol 17-valerate pellets were placed intraperitoneally. An experimental model of endometriosis was created in all the animals. To create the experimental model, an approximately 1-cm long section of the uterus was taken, primarily from the right horn of the uterus. Autologous fragments were then placed between the peritoneum and muscle. The animals were divided into 3 groups: Group A, treated only with the vehicle used for curcumin and deferoxamine; group B, treated with curcumin (100 mg/kg body weight); and group C, treated with deferoxamine + curcumin (100 mg/kg body weight). After biopsy samples were obtained, the sections were stained with hematoxylin and eosin. Immunostaining for cytokeratin-7 and proliferating cell nuclear antigen (PCNA) was performed. Blood iron levels were measured using a Perkin Elmer AAnalyst 800 Atomic Absorption Spectrophotometer. Results. The endometrial implant size increased in Group A, but treatment with curcumin (p = 0.01) and deferoxamine + curcumin (p = 0.007) reduced the implant size. In ectopic endometrial epithelial cells, there were significant decreases in PCNA immunoreactivity between groups A and B (p = 0.044) and between groups A and C (p = 0.033). Conclusion. Treatment with curcumin alone and/or in combination with deferoxamine contributed to a reduction in implant size and cell proliferation in a rat endometriosis model. Iron-chelating agents may act in the same manner when used in women with endometriosis; however, further studies from different perspectives are still needed. Key words curcumin, endometriosis, deferoxamine, PCNA

(27) - Kizilay G, Cakmak H, Arici A. Endometriosis and implantation. Balkan Med J. 2007;24:90–97. - Ihara T, Uchiide I, Sugamata M. Light and electron microscopic evaluation of antileukotriene therapy for experimental rat endometriosis. Fertil Steril. 2004;81:819–823. - Sharpe-Timms KL. Using rats as a research model for the study of endometriosis. Ann N Y Acad Sci. 2002;955:318–327. - Rezende CAL, Silva AL, Junior JLS, Gobbi H, Martins MMF. Experimental model for endometriosis-comparative histological study between the ectopic and eutopic endometrium. Acta Cír Bras. 1997;12:226–230. - Lousse JC, Defrere S, Van Langendonckt A, et al. Iron storage is significantly ıncreased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid. Fertil Steril. 2009;9:1668–1675. - Defrere S, Van Langendonckt A, Vaesen S, et al. Iron overload enhances epithelial cell proliferation in endometriotic lesions induced in a murine model. Hum Reprod. 2006;21:2810–2816. - Van Langendonckt A, Casanas-Roux F, Eggermont J, Donnez J. Characterization of iron deposition in endometriotic lesions induced in the nude mouse model. Hum Reprod. 2004;19:1265–1271. - Langlois A, Bietiger W, Mandes K, et al. Overexpression of vascular endothelial growth factor in vitro using deferoxamine: A new drug to increase islet vascularization during transplantation. Transplant Proc. 2008;40:473–476. - Wu MH, Chen KF, Lin SC, Lgu CW, Tsai SJ. Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1α. Am J Pathol. 2007;70:590–598. - Srichairatanakool S, Thephinlap C, Phisalaphong C, Porter JB, Fucharoen S. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Med Chem. 2007;3:469–474. - Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65: 1631–1635. - Kim KH, Lee EN, Park JK, et al. Curcumin attenuates TNF-α-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells. Phytother Res. 2012;26:1037–1047. - Seval Y, Cakmak H, Kayisli UA, Arici A. Estrogen-mediated regulation of p38 mitogen-activated protein kinase (MAPK) in human endome-trium. J Clin Endocrinol Metab. 2006;91:2349–2357. - Ricci AG, Olivares CN, Bilotas MA, et al. Natural therapies assessment for the treatment of endometriosis. Hum Reprod. 2013;28:178–188. - Nenicu A, Körbel C, Gu Y, Menger MD, Laschke MW. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions. Hum Reprod. 2014;29:1011–1024. - Zhang Y, Cao H, Hu YY, Wang H, Zhang CJ. Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis. Int Jour of Mol Med. 2011;27:87–94. - Defrère S, Lousse JC, González-Ramos R, Colette S, Donnez J, Van Langendonckt A. Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Mol Hum Reprod. 2008;14:377–85. - Van Langendonckt A, Casanas-Roux F, Donnez J. Iron overload in the peritoneal cavity of women with pelvic endometriosis. Fertil Steril. 2002;78:712–718. - Hendarto HHH, Kuswojo HKK, Sa’adi AAS, Ramelan WWR, Sudiana IKIKS. The role of curcumin supplementation on implant growth and ferti-lization result of experimental endometriosis in mice. Fertil Steril. 2010;94:205. - Wieser F, Yu J, Park J, Sidell N, Taylor RN. Curcumin suppresses angiogenesis, cell proliferation and induces apoptosis in an in vitro model of endometriosis. Fertil Steril. 2007;88:204–205. - Jana S, Rudra DS, Paul S, Snehasikta S. Curcumin delays endometriosis development by inhibiting MMP-2 activity. Indian J Biochem Biophys. 2012;49:342–348. - Jana S, Paul S, Swarnakar S. Curcumin as anti-endometriotic agent: Implication of MMP-3 and intrinsic apoptotic pathway. Biochem Pharmacol. 2012;83:797–804. - Swarnakar S, Paul S. Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity. Indian J Biochem Biophys. 2009;46:59–65. - Poylin V, Fareed MU, O’Neal P, et al. The NF-Kappaβ inhibitor curcumin blocks sepsis-induced muscle proteolysis. Mediators Inflamm. 2008;2008:ID:317851. - Kim YS, Ahn Y, Hong MH, et al. Curcumin attenuates inflammatory responses of TNFα-stimulated human endothelial cells. J Cardiovasc Pharmacol. 2007;50:41–49. - Veillat V, Lavoie CH, Metz CN, Roger T, Labelle Y, Akoum A. Involvement of nuclear factor-кB in macrophage migration inhibitory factor gene transcription up-regulation induced by interleukin-1β in ectopic endometrial cells. Fertil Steril. 2009;91:2148–2156. - Reinaldo GR, Langendonckt AV, Defrere S, et al. Involvement of the nuclear factor-кB pathway in the pathogenesis of endometriosis. Fertil Steril. 2010;94:1985–1994.